IRIC - Institute for Research in Immunology and Cancer

Primary navigation

  • About
    • Our Institute
    • Governance
    • News
    • Events
    • Grants
  • Research
    • Importance of research
    • Principal Investigators
    • Research topics
    • Platforms and infrastructures
    • Publications
    • Lectures
  • Training
    • Study at IRIC
    • Our programs
    • Submit your application
  • Valorization
  • Careers
    • Available positions
    • Spontaneous application
  • Support research
    • Make a donation
    • Get involved
    • Other ways to give
    • Donor impact
    • Our donors
  • Directory
  • Tools
  • Press
  • Contact
  • Support research
    • Make a donation
    • Get involved
    • Other ways to give
    • Donor impact
    • Our donors
  • Search
  • FR

Breadcrumb

  • Home
  • Search
  • Home

Search

173 results


Publications — IRIC January 1, 2023

Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD.

Claveau JS, LeBlanc R, Ahmad I, Delisle JS, Cohen S, Kiss T, Bambace NM, Bernard L, Lachance S, Roy DC, Sauvageau G, Veilleux O, Roy J
Transplant Cell Ther 2023-01-01 ;29( 1 ):44.e1-44.e9.


Publications — IRIC January 1, 2023

Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.

Lachance S, Bourguignon A, Boisjoly JA, Bouchard P, Ahmad I, Bambace N, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Veilleux O, Zehr J, Chagnon M, Roy J
Transplant Cell Ther 2023-01-01 ;29( 1 ):34.e1-34.e7.


Publications — IRIC September 13, 2022

Unified gene expression signature of novel NPM1 exon 5 mutations in acute myeloid leukemia.

Lisi V, Blanchard E, Vladovsky M, Audemard E, Ferghaly A, Lemieux S, Hébert J, Sauvageau G, Lavallée VP
Blood Adv 2022-09-13 ;6( 17 ):5160-5164.


Publications — IRIC August 23, 2022

HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.

Moison C, Spinella JF, Chagraoui J, Lavallée VP, Lehnertz B, Thiollier C, Boivin I, Mayotte N, MacRae T, Marinier A, Hébert J, Sauvageau G
Blood Adv 2022-08-23 ;6( 16 ):4793-4806.


Publications — IRIC August 22, 2022

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.

Kadri Y, Phan M, Bambace N, Bernard L, Cohen S, Delisle JS, Kiss T, Lachance S, Roy DC, Sauvageau G, Veilleux O, Roy J, Ahmad I
Curr Oncol 2022-08-22 ;29( 8 ):5955-5962.


Publications — IRIC July 1, 2022

Hyaluronic acid-GPRC5C signalling promotes dormancy in haematopoietic stem cells.

Zhang YW, Mess J, Aizarani N, Mishra P, Johnson C, Romero-Mulero MC, Rettkowski J, Schönberger K, Obier N, Jäcklein K, Woessner NM, Lalioti ME, Velasco-Hernandez T, Sikora K, Wäsch R, Lehnertz B, Sauvageau G, Manke T, Menendez P, Walter SG, Minguet S, Laurenti E, Günther S, Grün D, Cabezas-Wallscheid N
Nat Cell Biol 2022-07-01 ;24( 7 ):1038-1048.


Publications — IRIC July 1, 2022

UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities.

Dumont-Lagacé M, Feghaly A, Meunier MC, Finney M, Van't Hof W, Masson Frenet E, Sauvageau G, Cohen S
Transplant Cell Ther 2022-07-01 ;28( 7 ):410.e1-410.e5.


Publications — IRIC June 28, 2022

CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells.

Ansari U, Tomellini E, Chagraoui J, Lehnertz B, Mayotte N, Bordeleau ME, Roux PP, Sauvageau G
Blood Adv 2022-06-28 ;6( 12 ):3626-3631.


Publications — IRIC May 19, 2022

Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.

Baran N, Lodi A, Dhungana Y, Herbrich S, Collins M, Sweeney S, Pandey R, Skwarska A, Patel S, Tremblay M, Kuruvilla VM, Cavazos A, Kaplan M, Warmoes MO, Veiga DT, Furudate K, Rojas-Sutterin S, Haman A, Gareau Y, Marinier A, Ma H, Harutyunyan K, Daher M, Garcia LM, Al-Atrash G, Piya S, Ruvolo V, Yang W, Shanmugavelandy SS, Feng N, Gay J, Du D, Yang JJ, Hoff FW, Kaminski M, Tomczak K, Eric Davis R, Herranz D, Ferrando A, Jabbour EJ, Emilia Di Francesco M, Teachey DT, Horton TM, Kornblau S, Rezvani K, Sauvageau G, Gagea M, Andreeff M, Takahashi K, Marszalek JR, Lorenzi PL, Yu J, Tiziani S, Hoang T, Konopleva M
Nat Commun 2022-05-19 ;13( 1 ):2801.


Publications — IRIC March 7, 2022

CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia.

He L, Arnold C, Thoma J, Rohde C, Kholmatov M, Garg S, Hsiao CC, Viol L, Zhang K, Sun R, Schmidt C, Janssen M, MacRae T, Huber K, Thiede C, Hébert J, Sauvageau G, Spratte J, Fluhr H, Aust G, Müller-Tidow C, Niehrs C, Pereira G, Hamann J, Tanaka M, Zaugg JB, Pabst C
EMBO Mol Med 2022-03-07 ;e14990.


Publications — IRIC March 1, 2022

Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.

Veilleux O, Claveau JS, Alaoui H, Roy J, Ahmad I, Delisle JS, Kiss T, Bambace NM, Bernard L, Cohen S, Sauvageau G, Fleury I, Mollica L, Roy DC, Serroukh Y, Lachance S
Transplant Cell Ther 2022-03-01 ;28( 3 ):145-151.


Publications — IRIC February 1, 2022

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.

LeBlanc R, Ahmad I, Terra R, Boudreault JS, Ogez D, Lamore K, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Lemieux-Blanchard E, Sauvageau G, Sebag M, Roy DC, Roy J
Bone Marrow Transplant 2022-02-01 ;57( 2 ):252-260.


Publications — IRIC January 25, 2022

Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.

Krosl J, Bordeleau ME, Moison C, MacRae T, Boivin I, Mayotte N, Gracias D, Baccelli I, Lavallée VP, Bisaillon R, Lehnertz B, Mendoza-Sanchez R, Ruel R, Bertomeu T, Coulombe-Huntington J, Boucher G, Noronha N, Pabst C, Tyers M, Gendron P, Lemieux S, Barabé F, Marinier A, Hébert J, Sauvageau G
Blood Adv 2022-01-25 ;6( 2 ):509-514.


Publications — IRIC December 23, 2021

HLF expression defines the human hematopoietic stem cell state.

Lehnertz B, Chagraoui J, MacRae T, Tomellini E, Corneau S, Mayotte N, Boivin I, Durand A, Gracias D, Sauvageau G
Blood 2021-12-23 ;138( 25 ):2642-2654.


Publications — IRIC November 11, 2021

Legal and Ethical Considerations for the Design and Use of Web Portals for Researchers, Clinicians, and Patients: Scoping Literature Review.

Lang M, Lemieux S, Hébert J, Sauvageau G, Zawati MH
J Med Internet Res 2021-11-11 ;23( 11 ):e26450.


Publications — IRIC August 12, 2021

A genetic screen in Drosophila uncovers the multifaceted properties of the NUP98-HOXA9 oncogene.

Gavory G, Baril C, Laberge G, Bidla G, Koonpaew S, Sonea T, Sauvageau G, Therrien M
PLoS Genet 2021-08-12 ;17( 8 ):e1009730.


Publications — IRIC July 1, 2021

Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.

Herbrich S, Baran N, Cai T, Weng C, Aitken MJL, Post SM, Henderson J, Shi C, Richard-Carpentier G, Sauvageau G, Baggerly K, Al-Atrash G, Davis RE, Daver N, Zha D, Konopleva M
J Immunother Cancer 2021-07-01 ;9( 7 ):.


Publications — IRIC April 30, 2021

Cut-like homeobox 1 (CUX1) tumor suppressor gene haploinsufficiency induces apoptosis evasion to sustain myeloid leukemia.

Supper E, Rudat S, Iyer V, Droop A, Wong K, Spinella JF, Thomas P, Sauvageau G, Adams DJ, Wong CC
Nat Commun 2021-04-30 ;12( 1 ):2482.


Publications — IRIC April 13, 2021

Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes.

Ehx G, Larouche JD, Durette C, Laverdure JP, Hesnard L, Vincent K, Hardy MP, Thériault C, Rulleau C, Lanoix J, Bonneil E, Feghaly A, Apavaloaei A, Noronha N, Laumont CM, Delisle JS, Vago L, Hébert J, Sauvageau G, Lemieux S, Thibault P, Perreault C
Immunity 2021-04-13 ;54( 4 ):737-752.e10.


Publications — IRIC March 16, 2021

Zinc finger protein E4F1 cooperates with PARP-1 and BRG1 to promote DNA double-strand break repair.

Moison C, Chagraoui J, Caron MC, Gagné JP, Coulombe Y, Poirier GG, Masson JY, Sauvageau G
Proc Natl Acad Sci U S A 2021-03-16 ;118( 11 ):.


Publications — IRIC January 7, 2021

UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.

Chagraoui J, Girard S, Spinella JF, Simon L, Bonneil E, Mayotte N, MacRae T, Coulombe-Huntington J, Bertomeu T, Moison C, Tomellini E, Thibault P, Tyers M, Marinier A, Sauvageau G
Cell Stem Cell 2021-01-07 ;28( 1 ):48-62.e6.


Publications — IRIC January 1, 2021

UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections.

Dumont-Lagacé M, Li Q, Tanguay M, Chagraoui J, Kientega T, Cardin GB, Brasey A, Trofimov A, Carli C, Ahmad I, Bambace NM, Bernard L, Kiss TL, Roy J, Roy DC, Lemieux S, Perreault C, Rodier F, Dufresne SF, Busque L, Lachance S, Sauvageau G, Cohen S, Delisle JS
Transplant Cell Ther 2021-01-01 ;27( 1 ):76.e1-76.e9.


Publications — IRIC December 1, 2020

Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors.

Claveau JS, Cohen S, Ahmad I, Delisle JS, Kiss T, Lachance S, Sauvageau G, Busque L, Brito RM, Bambace N, Bernard L, Roy DC, Roy J
Eur J Haematol 2020-12-01 ;105( 6 ):808-811.


Publications — IRIC September 27, 2020

Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only.

LeBlanc R, Claveau JS, Ahmad I, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Roy DC, Sauvageau G, Roy J
Clin Transplant 2020-09-27 ;e14099.


Publications — IRIC February 13, 2020

High frequency of germline RUNX1 mutations in RUNX1 mutated AML patients.

Simon L, Spinella JF, Yao CY, Lavallée VP, Boivin I, Boucher G, Audemard E, Bordeleau ME, Lemieux S, Hebert J, Sauvageau G
Blood 2020-02-13 ;.


Publications — IRIC January 31, 2020

Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.

Cohen S, Roy J, Lachance S, Delisle JS, Marinier A, Busque L, Roy DC, Barabé F, Ahmad I, Bambace N, Bernard L, Kiss T, Bouchard P, Caudrelier P, Landais S, Larochelle F, Chagraoui J, Lehnertz B, Corneau S, Tomellini E, van Kampen JJA, Cornelissen JJ, Dumont-Lagacé M, Tanguay M, Li Q, Lemieux S, Zandstra PW, Sauvageau G
Lancet Haematol 2020-01-31 ;7( 2 ):e134-e145.


Publications — IRIC December 21, 2019

Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia.

Kettyle LM, Lebert-Ghali CE, Grishagin IV, Dickson GJ, O'Reilly PG, Simpson DA, Bijl JJ, Mills KI, Sauvageau G, Thompson A
Cancers (Basel) 2019-12-21 ;11( 12 ):.


Publications — IRIC December 19, 2019

Genetic characterization of ABT-199 sensitivity in human AML.

Bisaillon R, Moison C, Thiollier C, Krosl J, Bordeleau ME, Lehnertz B, Lavallée VP, MacRae T, Mayotte N, Labelle C, Boucher G, Spinella JF, Boivin I, D'Angelo G, Lavallée S, Marinier A, Lemieux S, Hébert J, Sauvageau G
Leukemia 2019-12-19 ;34( 1 ):63-74.


Publications — IRIC December 2, 2019

Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting.

Tremblay G, Rousseau B, Marquis M, Beaubois C, Sauvageau G, Hébert J
Appl Health Econ Health Policy 2019-12-02 ;17( 6 ):827-839.


Publications — IRIC November 29, 2019

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.

Angenendt L, Bormann E, Pabst C, Alla V, Görlich D, Braun L, Dohlich K, Schwöppe C, Bohlander SK, Arteaga MF, Wethmar K, Hartmann W, Angenendt A, Kessler T, Mesters RM, Stelljes M, Rothenberg-Thurley M, Spiekermann K, Hébert J, Sauvageau G, Valk PJM, Löwenberg B, Serve H, Müller-Tidow C, Lenz G, Wörmann BJ, Sauerland MC, Hiddemann W, Berdel WE, Krug U, Metzeler KH, Mikesch JH, Herold T, Schliemann C
Leukemia 2019-11-29 ;33( 12 ):2830-2841.


Publications — IRIC November 17, 2019

UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal.

Chagraoui J, Lehnertz B, Girard S, Spinella JF, Fares I, Tomellini E, Mayotte N, Corneau S, MacRae T, Simon L, Sauvageau G
PLoS ONE 2019-11-17 ;14( 11 ):e0224900.


Publications — IRIC September 12, 2019

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients.

Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Roy J, Lachance S
Biol. Blood Marrow Transplant. 2019-09-12 ;.


Publications — IRIC September 1, 2019

Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis.

Roy DC, Lachance S, Cohen S, Delisle JS, Kiss T, Sauvageau G, Busque L, Ahmad I, Bernard L, Bambace N, Boumédine RS, Guertin MC, Rezvani K, Mielke S, Perreault C, Roy J
Br. J. Haematol. 2019-09-01 ;186( 5 ):754-766.


Publications — IRIC August 22, 2019

A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2.

Dubois EL, Guitton-Sert L, Béliveau M, Parmar K, Chagraoui J, Vignard J, Pauty J, Caron MC, Coulombe Y, Buisson R, Jacquet K, Gamblin C, Gao Y, Laprise P, Lebel M, Sauvageau G, D d'Andrea A, Masson JY
Nucleic Acids Res. 2019-08-22 ;47( 14 ):7532-7547.


Publications — IRIC August 1, 2019

Targeted variant detection using unaligned RNA-Seq reads.

Audemard EO, Gendron P, Feghaly A, Lavallée VP, Hébert J, Sauvageau G, Lemieux S
Life Sci Alliance 2019-08-01 ;2( 4 ):.


Publications — IRIC July 23, 2019

Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Term Hematopoietic Stem Cells.

Tomellini E, Fares I, Lehnertz B, Chagraoui J, Mayotte N, MacRae T, Bordeleau MÈ, Corneau S, Bisaillon R, Sauvageau G
Cell Rep 2019-07-23 ;28( 4 ):1063-1073.e5.


Publications — IRIC July 18, 2019

Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.

Garg S, Reyes-Palomares A, He L, Bergeron A, Lavallée VP, Lemieux S, Gendron P, Rohde C, Xia J, Jagdhane P, Müller-Tidow C, Lipka DB, Imren S, Humphries RK, Waskow C, Vick B, Jeremias I, Richard-Carpentier G, Hébert J, Sauvageau G, Zaugg JB, Barabé F, Pabst C
Blood 2019-07-18 ;134( 3 ):263-276.


Publications — IRIC July 8, 2019

Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.

Baccelli I, Gareau Y, Lehnertz B, Gingras S, Spinella JF, Corneau S, Mayotte N, Girard S, Frechette M, Blouin-Chagnon V, Leveillé K, Boivin I, MacRae T, Krosl J, Thiollier C, Lavallée VP, Kanshin E, Bertomeu T, Coulombe-Huntington J, St-Denis C, Bordeleau ME, Boucher G, Roux PP, Lemieux S, Tyers M, Thibault P, Hébert J, Marinier A, Sauvageau G
Cancer Cell 2019-07-08 ;36( 1 ):84-99.e8.


Publications — IRIC April 1, 2019

Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.

Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Roy J, Lachance S
Leuk. Res. 2019-04-01 ;79:75-80.


Publications — IRIC February 26, 2019

Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition.

Moison C, Lavallée VP, Thiollier C, Lehnertz B, Boivin I, Mayotte N, Gareau Y, Fréchette M, Blouin-Chagnon V, Corneau S, Lavallée S, Lemieux S, Marinier A, Hébert J, Sauvageau G
Blood Adv 2019-02-26 ;3( 4 ):552-563.


Publications — IRIC July 19, 2018

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.

Marquis M, Beaubois C, Lavallée VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, Schwarer A, Grimwade D, Grey W, Hills RK, Vyas P, Russell N, Sauvageau G, Hébert J
Blood Cancer J 2018-07-19 ;8( 8 ):68.


Publications — IRIC July 5, 2018

UM171 Enhances Lentiviral Gene Transfer and Recovery of Primitive Human Hematopoietic Cells.

Ngom M, Imren S, Maetzig T, Adair JE, Knapp D, Chagraoui J, Fares I, Bordeleau ME, Sauvageau G, Leboulch P, Eaves C, Humphries RK
Mol Ther Methods Clin Dev 2018-07-05 ;10:156-164.


Publications — IRIC June 1, 2018

Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin.

Lavallée VP, Chagraoui J, MacRae T, Marquis M, Bonnefoy A, Krosl J, Lemieux S, Marinier A, Pabst C, Rivard GÉ, Hébert J, Sauvageau G
Leukemia 2018-06-01 ;32( 6 ):1349-1357.


Publications — IRIC April 1, 2018

MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia.

Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivtsov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A
Cancer Discov 2018-04-01 ;8( 4 ):478-497.


Publications — IRIC November 16, 2017

H3K27M/I mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations.

Lehnertz B, Zhang YW, Boivin I, Mayotte N, Tomellini E, Chagraoui J, Lavallée VP, Hébert J, Sauvageau G
Blood 2017-11-16 ;130( 20 ):2204-2214.


Publications — IRIC November 15, 2017

Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity.

Simon L, Lavallée VP, Bordeleau ME, Krosl J, Baccelli I, Boucher G, Lehnertz B, Chagraoui J, MacRae T, Ruel R, Chantigny Y, Lemieux S, Marinier A, Hébert J, Sauvageau G
Clin. Cancer Res. 2017-11-15 ;23( 22 ):6969-6981.


Publications — IRIC November 1, 2017

UBAP2L is amplified in a large subset of human lung adenocarcinoma and is critical for epithelial lung cell identity and tumor metastasis.

Aucagne R, Girard S, Mayotte N, Lehnertz B, Lopes-Paciencia S, Gendron P, Boucher G, Chagraoui J, Sauvageau G
FASEB J. 2017-11-01 ;31( 11 ):5012-5018.


Publications — IRIC July 27, 2017

MiSTIC, an integrated platform for the analysis of heterogeneity in large tumour transcriptome datasets.

Lemieux S, Sargeant T, Laperrière D, Ismail H, Boucher G, Rozendaal M, Lavallée VP, Ashton-Beaucage D, Wilhelm B, Hébert J, Hilton DJ, Mader S, Sauvageau G
Nucleic Acids Res. 2017-07-27 ;45( 13 ):e122.


Publications — IRIC July 1, 2017

AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.

Zhou F, Liu Y, Rohde C, Pauli C, Gerloff D, Köhn M, Misiak D, Bäumer N, Cui C, Göllner S, Oellerich T, Serve H, Garcia-Cuellar MP, Slany R, Maciejewski JP, Przychodzen B, Seliger B, Klein HU, Bartenhagen C, Berdel WE, Dugas M, Taketo MM, Farouq D, Schwartz S, Regev A, Hébert J, Sauvageau G, Pabst C, Hüttelmaier S, Müller-Tidow C
Nat. Cell Biol. 2017-07-01 ;19( 7 ):844-855.


Publications — IRIC June 22, 2017

EPCR expression marks UM171-expanded CD34(+) cord blood stem cells.

Fares I, Chagraoui J, Lehnertz B, MacRae T, Mayotte N, Tomellini E, Aubert L, Roux PP, Sauvageau G
Blood 2017-06-22 ;129( 25 ):3344-3351.

Load more results
Search filters

Search filters

Open accordion

Search filters

Close accordion
Active filters
Publications
Guy Sauvageau
Types of content
  • Publications (173)
Principal Investigators
  • Anne Marinier (16)
  • Benjamin Kwok (1)
  • Brian Wilhelm (12)
  • Claude Perreault (10)
  • David Knapp (3)
  • Guy Sauvageau (173)
  • Julie Lessard (12)
  • Louis Gaboury (2)
  • Marc Therrien (2)
  • Michael Tyers (3)
  • Michel Bouvier (1)
  • Philippe P. Roux (4)
  • Pierre Thibault (7)
  • Sylvain Meloche (8)
  • Sylvie Mader (1)
  • Sébastien Lemieux (33)
  • Trang Hoang (5)
Research topics
  • Cell Division & Migration (14)
  • Cell Signaling & Protein Dynamics (20)
  • Chemical & Structural Biology (24)
  • Computational Analysis & Modeling (50)
  • Genomics & Epigenetics (173)
  • Immunology & Hematopoiesis (173)
  • Targeted Therapies & Diagnostics (173)
Years
  • 2023 (2)
  • 2022 (11)
  • 2021 (9)
  • 2020 (4)
  • 2019 (14)
  • 2018 (4)
  • 2017 (11)
  • 2016 (9)
  • 2015 (6)
  • 2014 (11)
  • 2013 (6)
  • 2012 (6)
  • 2011 (6)
  • 2010 (8)
  • 2009 (5)
  • 2008 (6)
  • 2007 (5)
  • 2006 (6)
  • 2005 (5)
  • 2004 (5)
  • 2003 (4)
  • 2002 (4)
  • 2001 (4)
  • 2000 (1)
  • 1999 (3)
  • 1998 (3)
  • 1997 (4)
  • 1996 (4)
  • 1995 (2)
  • 1994 (1)
  • 1991 (1)
  • 1990 (2)
  • 1988 (1)
IRIC - Institute for Research in Immunology and Cancer

Primary navigation

  • About
  • Research
  • Training
  • Valorization
  • Careers
  • Support research
  • Directory
  • Press
  • Tools
  • Contact

IRIC | Université de Montréal
2950, Chemin de Polytechnique
Marcelle-Coutu Pavilion
Montréal, Québec  H3T 1J4
Canada

How to get to IRIC?

Phone
+1 514-343-7770
Fax
+1 514-343-7780

Social networks

Subscribe to the newsletter
Subscribe to the newsletter

Secondary navigation

  • Terms and conditions
  • Privacy policy

© 2003-2023 IRIC. All rights reserved.

Website by Principal